Nexeon MedSystems

Related by string. * : Nexeon / Medsystems : EP MedSystems . Bender MedSystems . Conor Medsystems Inc. . EP MedSystems shareholders . EP MedSystems develops . PRNewswire FirstCall Conor Medsystems . Conor Medsystems . MedSystems . Conor MedSystems . Medsystems Continental Cable * *

Related by context. Frequent words. (Click for all words.) 68 AXYS Design Automation 66 Amorcyte 64 Agios Pharmaceuticals 62 MedPro Safety Products 62 VIA Pharmaceuticals 62 Neogenix Oncology 61 InPlay Technologies 61 Bayhill Therapeutics 61 Bovie Medical 60 CureDM 60 bluebird bio 60 Portola Pharmaceuticals 60 MacuSight 60 CardioTech International 60 OTCBB NEOP diversified 60 MultiCell Technologies 60 Accentia Biopharmaceuticals 59 ARCA biopharma 59 Nastech Pharmaceutical Company 59 Provides Shareholder 59 OPKO Health 59 OncoGenex Technologies 59 FoxHollow Technologies Inc. 59 XTENT 59 Atritech 59 Ambit Biosciences 59 Inovio Pharmaceuticals 59 AngioScore 59 Genaera Corporation 59 FluoroPharma 59 Merrimack Pharmaceuticals 59 CardioVascular BioTherapeutics Inc. 59 Urodynamix 58 MacroPore Biosurgery 58 Synergy Pharmaceuticals 58 Akela Pharma 58 Regado Biosciences 58 Cornerstone BioPharma 58 IntelliPharmaCeutics 58 Transcept Pharmaceuticals 58 Ore Pharmaceuticals 58 Xtent 58 Amorfix Life Sciences 58 WGI Heavy Minerals 58 Cempra Pharmaceuticals 58 Files Shelf Registration Statement 58 Vaccinex 58 Hyperion Therapeutics 58 Hybridon 58 Panacos Pharmaceuticals 58 Salmedix 58 Nanotherapeutics 58 Immunicon Corporation 58 Celator Pharmaceuticals 58 Discusses Q4 58 Anthera Pharmaceuticals 57 Callisto Pharmaceuticals Inc. 57 Pacific Biomarkers 57 Northstar Neuroscience Inc. 57 Vion Pharmaceuticals Inc. 57 Synergetics USA 57 * Azixa 57 Neurobiological Technologies 57 LeMaitre Vascular 57 Seaside Therapeutics 57 TSX COM 57 ImmunoCellular Therapeutics 57 IR BioSciences Holdings 57 Altus Pharmaceuticals 57 Announces FDA Clearance 57 Relypsa 57 Urigen Pharmaceuticals Inc. 57 Intellipharmaceutics International 57 Nasdaq VRTX 57 Initiates Phase II 57 AOptix Technologies 57 AcuNetx 57 Cyclacel Pharmaceuticals 57 OncoGenex Pharmaceuticals 57 Jumps Higher 57 Maxim Pharmaceuticals 57 Quark Pharmaceuticals 57 Transave 57 Neuronetics 57 Peptimmune 57 Covalon Technologies Ltd. 57 Presidio Pharmaceuticals 57 Ortec 57 AmpliMed 57 Enable IPC Corporation 56 Interpharm 56 Lorus Therapeutics 56 Sunesis Pharmaceuticals 56 IntraLase Corp. 56 ChondroGene 56 IDEV 56 EV3 56 Larry W. Reaugh 56 SomaLogic 56 Metabasis Therapeutics 56 Bonaventure Enterprises

Back to home page